In addition, we kept open the possibility that the ETF will continue to rise and could reach around 108.45. To see how we ...

Sarepta Therapeutics said it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based ...

Nestled in a prime location, this exceptional 5 bedroom house offers the perfect blend of spacious living and entrepreneurial potential. The property boasts a conveniently situated shop at the back, ...

Analysts have set 12-month price targets for Sarepta Therapeutics, revealing an average target of $168.79, a high estimate of ...